Fusariosis
📧 Sign up to get email alerts when something new happens for Fusariosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-02-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for Vfend (voriconazole) submitted by Roerig.
-
FDA approval · 2026-01-28FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Immunomonitoring of Mold Invasive Infections
A clinical trial evaluating immunomonitoring of mold invasive fungal infections is currently recruiting, sponsored by Assistance Publique - …
-
FDA approval · 2023-03-09FDA Approved: VORICONAZOLE — Original Application (UBI Pharma Inc.)
FDA approved a generic version of voriconazole (UBI Pharma Inc.) via Original Application. The approval covers treatment of certain invasive…
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Anti-mold Azole in the Prophylaxis for Invasive Fusariosis [NA]
Clinical trial update for an anti-mold azole used as prophylaxis for invasive Fusariosis; trial completed with results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy [Phase 2]
A Phase 2 trial evaluating individualized voriconazole antifungal therapy has been suspended in immunocompromised patients with Aspergillosi…
-
CLINICAL_TRIALS trial_result · 2009-12-03Clinical Trial Update: Fusariosis in Solid-Organ Transplant Recipients
The clinical trial investigating Fusariosis in solid-organ transplant recipients has completed.